Historically, miR-21 was the first oncogenic miRNA to be identified [40] and can target a set of oncosuppressor genes including PTEN [41] and the metalloproteinase inhibitor TIMP3 which is involved in extracellular matrix remodeling, tumor infiltration, and angiogenesis [42, 43]. The gene discussed is PTEN; the disease is neoplasm.